Arvinas (ARVN) Current Assets (2017 - 2026)
Arvinas' Current Assets came in at $587.6 million for Q3 2026, down 28.9% from $826.3 million a year earlier and down 9.9% from the prior quarter.
Powered by 
Analysis
Arvinas (ARVN) Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Arvinas' Current Assets was $700.7 million, down 34.3% from FY2024.
- Current Assets carries a five-year compound annual growth rate of -0.1% (FY2020 to FY2025).
- Going back by year, Current Assets was $1.07 billion in FY2024 (-16.6%), $1.28 billion in FY2023 (+3.2%), $1.24 billion in FY2022 (-20.1%) and $1.55 billion in FY2021 (+120.8%).
- The Q3 2026 figure represents the lowest quarterly Current Assets since Q3 2020.
- Year-over-year, Current Assets has declined for eight consecutive quarters, with an average decline of 27.1% over the last eight quarters.
- The fastest year-over-year change in Current Assets over five years came in Q4 2021 (growth of 120.8%), and the weakest in Q1 2026 (a decline of 35.6%).
- Business Quant data shows ARVN's Current Assets at $652.2 million (Q2 2026), $630.7 million (Q1 2026) and $700.7 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 31.45 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Arvinas | 453.26 Mn | -1.97 Bn | 400,000.00 | 587.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 587.60 Mn |
| Jun 30, 2026 | 652.20 Mn |
| Mar 31, 2026 | 630.70 Mn |
| Dec 31, 2025 | 700.70 Mn |
| Sep 30, 2025 | 826.30 Mn |
| Jun 30, 2025 | 889.50 Mn |
| Mar 31, 2025 | 979.70 Mn |
| Dec 31, 2024 | 1.07 Bn |
| Sep 30, 2024 | 1.15 Bn |
| Jun 30, 2024 | 1.26 Bn |
| Mar 31, 2024 | 1.19 Bn |
| Dec 31, 2023 | 1.28 Bn |
| Sep 30, 2023 | 1.03 Bn |
| Jun 30, 2023 | 1.06 Bn |
| Mar 31, 2023 | 1.15 Bn |
| Dec 31, 2022 | 1.24 Bn |
| Sep 30, 2022 | 1.30 Bn |
| Jun 30, 2022 | 1.38 Bn |
| Mar 31, 2022 | 1.46 Bn |
| Dec 31, 2021 | 1.55 Bn |
API Access
Arvinas Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ARVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();